GLP-1 weight loss uses medications that act on glucagon-like peptide-1 pathways, which are involved in appetite, fullness, digestion, and blood sugar regulation
After eating, GLP-1 is secreted and begins its work in the body by causing the pancreas to secrete insulin
Histopathological examination under hematoxylin and eosin showed proliferation and dispersion of dendritic melanocytes in variable numbers in the entire thickness of acanthotic epithelium [Figure - 2]
According to the FDAs 2023 guidance, Ipamorelin is currently not eligible for compounding under Section 503A and is classified as a Category B bulk drug substance due to a lack of safety data
We integrate with EHR's so you can order from and receive lab results directly in your patient's chart Trusted by leading practitioners across the USA
In June 2023, the New England Journal of Medicine published the results of the Phase 2 retatrutide trial conducted by Eli Lilly